English
Investors
Shareholders
EQT logo
About
Teams
Sustainability
Investments
Media
Current portfolio
Arvelle Therapeutics
Dutch biotech company commercializing an epilepsy drug with unprecedented efficacy for refractory patients with partial onset seizures.
Sector
Healthcare
Country
Netherlands
Fund
LSP 6
Entry
2019
Web
arvelletx.com
Sector
Healthcare
Country
Netherlands
Fund
LSP 6
Entry
2019
Web
arvelletx.com
Investments
EQT logo